Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Nanomaterials to overcome microbial resistance?

World Sight Day 2020: I for an Eye

ICAR-NDRI Recruitment – Life Science/ Microbiology Apply

Nanomaterials to overcome microbial resistance?
  • BiotechToday
  • World

Nanomaterials to overcome microbial resistance?

bioxone October 9, 2020October 8, 2020

Prama Ghosh, Amity University Kolkata

Increasing resistance to antibiotics by infectious microbes is emerging as a serious threat to mankind. To tackle this problem, nanomaterials are rapidly rising by improving the power of existing antibiotics or producing altogether new antibacterial instruments.

An antibiotic works by inhibiting the synthesis of DNA, RNA or cell wall of the pathogen. The pathogen undergoes mutation by delivering their cell wall impermeable to drug molecules, overexpressing multidrug efflux siphons to remove drugs, reshuffling the genetic code of drug targets or secreting toxic enzymes to destroy the antibiotics before they reach their targets. Such an imbalance between the evolution of microbes and traditional antibiotics forced researchers to turn to nanomaterials for a solution.

In one category, nanomaterials are designed as carriers which can overcome cellular barriers of the pathogen and deliver the drug particles directly into the cytoplasm thereby destroying the pathogen. This increases the potency of the drug as there is less exposure of the drug molecules. The other category uses nanomaterials to break extracellular polymeric substances (EPS) and penetrate the EPS matrix to destroy the cell.

According to Ivanova and co-authors, sharp, blade-like nanostructures pierce into the bacteria which creates cell destructive pores. Nanomaterials can stretch the bacterial cell wall from two different contact points which causes disruption and deformation of bacterial cell walls. Nanomaterials can also work on more than one target by delivering multiple drug molecules due to which nanomaterials may turn into a backbone for treating bacterial diseases in the time of antibiotic resistance.

Also read : Distance-dependent preferential binding of N2H4 to mobile Lewis acid present in a series of Zn complexes takes place

Source: Gao, W., Zhang, L. Nanomaterials arising amid antibiotic resistance. Nat Rev Microbiol (2020). https://doi.org/10.1038/s41579-020-00469-5

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged antibiotic drug antibiotics clinical research drug delivery microbial resistance microbial resistance mechanisms microbial resistance to antibiotics Mutation nanomaterials nanomaterials application

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

ICAR-NDRI Recruitment – Life Science/ Microbiology Apply

bioxone October 9, 2020

-Shristi Sharma, Team bioXone ICAR-NDRI Recruitment – Life Science/ Microbiology Apply. ICAR-NDRI is recruiting for research positions. ICAR-NDRI Research Fellow Recruitment. Interested candidates can check out the SRF/Young Professional vacancies at ICAR-NDRI, as per the details given below: Online Applications are invited from the interested/eligible candidates to attend the online interview through video conferencing through […]

Related Post

  • BiotechToday
  • World

DeepHBV: A machine learning tool to aid in Hepatitis B integration site detection

BioTech Today July 9, 2021July 8, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Machine learning has been useful to us in several ways. It has helped in the development of self-driving cars, google assistant, weather prediction, image recognition, language translation, you-tube recommendation, and much more. Machine learning finds it to be very helpful in biology, health informatics, and medical sciences […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Role of the lncRNA complex HCP5 in glioma treatment

bioxone July 7, 2022July 7, 2022

Harini Balasubramanian, Anna University, Chennai The investigation of non-coding regions of the DNA, especially miRNA and long non-coding RNA (lncRNA), and their role in various disease phenotypes, has drawn the attention of scientists in recent years. Gliomas are neoplasias usually found in the brain, a stage IV progression of which leads to glioblastoma (GBM). GBM […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A new therapeutic target for stomach cancer discovered

bioxone December 17, 2020December 16, 2020

Husna, Amity University Kolkata More than one million people around the world are diagnosed with stomach cancer every year. Stomach cancer is an abnormal growth of the cells that tends to develop slowly over many years. Before true cancer develops, the early changes rarely cause any symptoms and therefore go undetected. In its advanced stage, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy